Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Clinical effect of ethanol co-use in patients with acute drug toxicity involving the use of central nervous system depressant recreational drugs.

Authors:
Eva-Carina Heier Florian Eyer Christian Rabe Stefanie Geith Paul I Dargan David M Wood Fridtjof Heyerdahl Alison M Dines Isabelle Giraudon Knut Erik Hovda Chris Yates Odd Martin Vallersnes Òscar Miró Matthias E Liechti Tobias Zellner

Eur J Emerg Med 2022 Apr 8. Epub 2022 Apr 8.

Division of Clinical Toxicology and Poison Control Centre Munich, Department of Internal Medicine II, TUM School of Medicine, Technical University of Munich, Germany.

Background And Importance: Patients who use recreational drugs frequently co-ingest ethanol, which is considered a central nervous system (CNS) depressant. The clinical relevance of this in acute toxicity involving other CNS depressants is not well described.

Objective: To assess the clinical impact of ethanol co-use in patients presenting to the emergency department (ED) with acute toxicity involving the use of CNS depressant drugs.

Design, Settings And Participants: A retrospective multicentre study using data from the Euro-DEN Plus database from January 2014 to December 2019.

Outcomes Measure And Analysis: Comparison of epidemiologic and clinical characteristics, ED and hospital management of patients with CNS depressant intoxication with or without ethanol co-use.

Main Results: Although 7644 (17.5%) of the 43 633 presentations were included, ethanol was co-ingested in 3811 (49.9%). In total 53.3% required medical treatment, 14 patients died. Patients with ethanol co-use more frequently presented with a Glasgow Coma Scale (GCS) ≤8 (34.1% vs. 22.4%; P  < 0.001), vomiting (8.1% vs. 4.6%; P  < 0.001), anxiety (12 % vs. 6.4%; P  < 0.001), agitation/aggression (22% vs. 14.7%; P  < 0.001), seizures (3.8% vs. 2.4%; P  < 0.001) and hypotension (7.5% vs. 4.6%; P  < 0.001). They more often required ambulance transport (85.5% vs. 76.5%; P  < 0.001), medical treatment (57.3% vs. 48.0%; P  < 0.001), hospitalization (27.7% vs. 18.9%; P  < 0.001), and admission to intensive care (12.2% vs. 4.0%; P  < 0.001). Subgroup analysis showed that GCS ≤8 was particularly common in patients who combined ethanol with opioids or gamma-hydroxybutyrate (GHB)/gamma-butyrolactone (GBL).

Conclusion: Co-use of ethanol with CNS-depressant drugs appears to increase the risk of adverse effects and is associated with a higher need for medical treatment, especially when ethanol is combined with opioids or GHB/GBL.

Download full-text PDF

Source
http://dx.doi.org/10.1097/MEJ.0000000000000932DOI Listing
April 2022

Publication Analysis

Top Keywords

toxicity involving
12
ethanol co-use
12
cns depressant
12
nervous system
8
co-use patients
8
central nervous
8
recreational drugs
8
involving cns
8
acute toxicity
8
patients
6
ethanol
5
comparison epidemiologic
4
epidemiologic clinical
4
clinical
4
clinical characteristics
4
analysis comparison
4
hospital management
4
management patients
4
patients cns
4
characteristics hospital
4

Keyword Occurance

Similar Publications

Characterization of Developmental Neurobehavioral Toxicity in a Zebrafish MPTP-Induced Model: A Novel Mechanism Involving Anemia.

Authors:
Haojia Dong Luying Mao Chenglian Bai Kaiwei Ye Han Wu Yuhang Lei Sunrui Yu Yi Liu Junyan Tao Wenhao Pan Hui Xu Jian Lin Jianhong Zhu Qiaoxiang Dong

ACS Chem Neurosci 2022 Jun 27. Epub 2022 Jun 27.

School of Public Health and Preventive Medicine, Wenzhou Medical University, Wenzhou 325035, China.

Zebrafish represent an economical alternative to rodents for developmental neurotoxicity (DNT) testing. Mechanistic understanding is the key to successfully translating zebrafish findings to humans. In the present study, we used a well-known dopaminergic (DA) neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a model chemical to uncover the molecular pathways for observed DNT effects. Read More

View Article and Full-Text PDF
June 2022
Similar Publications

Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease.

Authors:
Li-Kung Wu Surbhi Agarwal Chia-Hua Kuo Yen-Lun Kung Cecilia Hsuan Day Pi-Yu Lin Shinn-Zong Lin Dennis Jine-Yuan Hsieh Chih-Yang Huang Chien-Yi Chiang

Phytomedicine 2022 Jun 15;104:154250. Epub 2022 Jun 15.

Cardiovascular and Mitochondrial Related Disease Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan. Electronic address:

Background: Parkinson's disease (PD) is a neurodegenerative disorder involving the degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc). Cellular clearance mechanisms, including the autophagy-lysosome pathway, are commonly affected in the pathogenesis of PD. The lysosomal Ca channel mucolipin TRP channel 1 (TRPML1) is one of the most important proteins involved in the regulation of autophagy. Read More

View Article and Full-Text PDF
June 2022
Similar Publications

Environmental co-exposure of high temperature and Cu induce hormonal disturbance of cortisol signaling and altered responses of cellular defense genes in zebrafish.

Authors:
Kiyun Park Ihn-Sil Kwak

Sci Total Environ 2022 Jun 21;842:156555. Epub 2022 Jun 21.

Fisheries Science Institute, Chonnam National University, Yeosu 59626, South Korea; Department of Ocean Integrated Science, Chonnam National University, Yeosu 59626, South Korea. Electronic address:

Global warming is causing a continuous increase in environmental temperatures, which simultaneously activates toxic environmental stresses, such as heavy metal exposure, in aquatic ecosystems. The present study aimed at evaluating the effects of Cu toxicity along with increased temperature during zebrafish embryogenesis. Decreased survival rates were observed following combined exposure to high temperature and Cu. Read More

View Article and Full-Text PDF
June 2022
Similar Publications

Glycidamide and cis-2-butene-1,4-dial (BDA) as potential carcinogens and promoters of liver cancer - An in vitro study.

Authors:
Sofia Gouveia-Fernandes Armanda Rodrigues Carolina Nunes Catarina Charneira João Nunes Jacinta Serpa Alexandra M M Antunes

Food Chem Toxicol 2022 Jun 21;166:113251. Epub 2022 Jun 21.

Centro de Química Estrutural, Institute of Molecular Sciences, Departamento de Engenharia Química, Instituto Superior Técnico, Av. Rovisco Pais, 1049 001, Lisboa, Portugal. Electronic address:

Acrylamide and furan are environmental and food contaminants that are metabolized by cytochrome P450 2E1 (CYP2E1), giving rise to glycidamide and cis-2-butene-1,4-dial (BDA) metabolites, respectively. Both glycidamide and BDA are electrophilic species that react with nucleophilic groups, being able to introduce mutations in DNA and perform epigenetic remodeling. However, whereas these carcinogens are primarily metabolized in the liver, the carcinogenic potential of acrylamide and furan in this organ is still controversial, based on findings from experimental animal studies. Read More

View Article and Full-Text PDF
June 2022
Similar Publications

Combination of [Lu]Lu-DOTA-TATE Targeted Radionuclide Therapy and Photothermal Therapy as a Promising Approach for Cancer Treatment: In Vivo Studies in a Human Xenograft Mouse Model.

Authors:
Marina Simón Jesper Tranekjær Jørgensen Harshvardhan A Khare Camilla Christensen Carsten Haagen Nielsen Andreas Kjaer

Pharmaceutics 2022 Jun 16;14(6). Epub 2022 Jun 16.

Department of Clinical Physiology and Nuclear Medicine & Cluster for Molecular Imaging, Copenhagen University Hospital-Rigshospitalet & Department of Biomedical Sciences, University of Copenhagen, 2100 Copenhagen, Denmark.

Peptide receptor radionuclide therapy (PRRT) relies on α- and β-emitting radionuclides bound to a peptide that commonly targets somatostatin receptors (SSTRs) for the localized killing of tumors through ionizing radiation. A Lutetium-177 (Lu)-based probe linked to the somatostatin analog octreotate ([Lu]Lu-DOTA-TATE) is approved for the treatment of certain SSTR-expressing tumors and has been shown to improve survival. However, a limiting factor of PRRT is the potential toxicity derived from the high doses needed to kill the tumor. Read More

View Article and Full-Text PDF
June 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap